108770 ⎘
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor; Animal cells or tissues; Human cells or tissues; Vertebrate cells; Cells from the blood or the immune system Dendritic cells, e.g. Langherhans cells in the epidermis
USE OF A VARICELLOVIRUS TAP-INHIBITOR FOR THE INDUCTION OF TUMOR-OR VIRUS-SPECIFIC IMMUNITY AGAINST TEIPP
#602Generation of mature myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived linCD34CD43CD45progenitors
#603INTERFERON-alpha REGULATOR
#604HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants
#605Method for expanding monocytes
#606MATURATION OF DENDRITIC CELLS
#607METHODS FOR ENHANCING INNATE AND ADAPTIVE IMMUNITY AND ANTIGEN IMMUNOGENICITY
#608CELLULAR VACCINE
#609Methods and compositions for transforming dendritic cells and activating cells
#610Differentiation of primate pluripotent stem cells to hematopoietic lineage cells
#611Separating material and method for collecting cell or the like using the same
#612Modulation of stem and progenitor cell differentiation, assays, and uses thereof
#613Method for generating dendritic cells employing decreased temperature
#614Method for producing dendritic cells
#615INDUCTION OF DENDRITIC CELL DEVELOPMENT WITH MACROPHAGE-COLONY STIMULATING FACTOR (M-CSF) RECEPTOR LIGANDS
#616DENDRITIC CELLS
#617Inhibition of dendritic cell-driven regulatory T cell activation and potentiation of tumor antigen-specific T cell responses by interleukin-15 and MAP kinase inhibitor
#618Engineered Dendritic Cells and Uses for the Treatment of Cancer
#619Method for determining the immunogenicity of an antigen
#620RAPID GENERATION OF T CELL-INDEPENDENT ANTIBODY RESPONSES TO T CELL-DEPENDENT ANTIGENS
#621Method for activation treatment of antigen-presenting cell
#622Method for producing langerhans cells or interstitial dendritic cells or both from CD14+ monocytes
#623Dendritic cell stimulatory factor
#624Derivation of unlimited quantities of neutrophils or monocyte/dendritic cells
#625Dendritic cell compositions and methods
#626Dendritic cells, uses therefor, and vaccines and methods comprising the same
#627Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens
#628Pharmaceutical composition for inducing an immune response in a human or animal
#629Preparation of inactivated artificial antigen presenting cells and their use in cell therapies
#630Mature type-1 polarized dendritic cells with enhanced IL-12 production and methods of serum-free production and use
#631Cancer vaccines and vaccination methods
#632Cancer vaccines and vaccination methods
#633Methionine Enkephalin as an Adjuvant for Vaccine Immunizations
#634Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF)
#635Compositions and Methods for Inducing the Activation of Immature Monocytic Dendritic Cells
#636COMPOSITIONS AND METHODS FOR PRIMING MONOCYTIC DENDRITIC CELLS AND T CELLS FOR TH-1 RESPONSE
#637Method for the Delivery of Exogenous Antigens into the Mhc Class I Presentation Pathway of Cells
#638Methods for Inducing the Differentiation of Blood Monocytes into Functional Dendritic Cells
#639Method for rapid generation of mature dendritic cells
#640Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells
#641Therapeutic Applications of Activation of Human Antigen-Presenting Cells Through Dectin-1
#642Method for culturing dendritic cells (DC) and cytokine-induced killer cells (D-CIK) and applications thereof
#643Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)
#644Methods For Producing Dendritic Cells That Have Acquired Ctl-Inducing Ability
#645Mature Dendritic Cell Compositions and Methods of Culturing Same
#646Immune regulation
#647Methods for Selecting Proteins that are Readily Presented as Antigens on Dendritic Cells
#648DIFFERENT DENDRITIC CELL SUBSETS
#649Dendritic Cells Generated Using GM-CSF and Interferon Alpha and Loaded with Heat-Treated and Killed Cancer Cells
#650METHOD OF INDUCING TOLERANCE TO BETAAP 1-42 AND MYELIN BASIC PROTEIN
#651Preloaded dendritic cell vaccines for treating cancer
#652Methods for inducing the differentiation of blood monocytes into functional dendritic cells
#653Peripheral blood mononuclear cells
#654Method for producing dendritic cells
#655Antibodies to protein markers associated with bone marrow stem cell differentiation into early progenitor dendritic cells
#656Cancer vaccine
#657Fungal immunostimulatory compositions
#658In vitro germinal centers
#659Therapeutical Composition Containing Dentritic Cells And Use Thereof
#660Immune Modulation By Regulating Expression Of The "Minor" Gene In Immune Dendritic Cells
#661Dendritic cells pulsed with a bisphosphonate
#662Porous membrane device that promotes the differentiation of monocytes into dendritic cells
#663Co-culture lymphoid tissue equivalent (LTE) for an artificial immune system (AIS)
#664Method for the direct culture of dendritic cells without a preceding centrifugation step
#665Medicaments for the immunotherapy of malignant tumors
#666Methods and compositions for maturing dendritic cells utilizing inosine-containing compounds
#667Mature dendritic cell compositions and methods for culturing same
#668Immunostimulatory nucleic acid molecules for activating dendritic cells
#669Artificial lymphoid tissue equivalent
#670Antibodies to dendritc cells and human dendritic cell populations and uses thereof
#671Vaccine composition comprising Flt3-ligand
#672Cancer vaccine based on brother of regulator of imprinted sites molecule
#673Methods related to immunostimulatory nucleic acid-induced interferon
#674Dendritic cell isolation methods
#675Method of forming dendritic cells from embryonic stem cells
#676Modulation of cytokine signaling regulators and applications for immunotherapy
#677Treating gastrointestinal diseases with modulators of retinoic acid
#678Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells
#679Dendritic cell presenting a-glycosylceramide derivative and antigent and usable in suppressing immune response
#680Rapid one-step generation of antigen loaded dendritic cell vaccine from precursors
#681Method for generating antigen-presenting cells
#682In vivo expanded NKT cells and methods of use thereof
#683Growth of human dendritic cells for cancer immunotherapy in closed system using microcarrier beads
#684Cultured cd14+ antigen presenting cells
#685Modulation of Fc gamma receptors for optimizing immunotherapy
#686Methods for repressing B cell autoantibody secretion and for treating autoimmune disorders by administration of hematopoietic stem cells and macrophage-colony stimulating factor
#687Method of preparing langerhans cell from cd14-positive cell being human peripheral blood mononuclear cell with use of notch ligand delta-1, gm-csf and tgf-ss
#688Use of dendritic cells (DCs) expressing interleukin 12 (IL-12)
#689Immunomodulation using altered dendritic cells
#690Novel uses of PPAR modulators and professional APCs manipulated by the same
#691Method of characterizing dendritic cells
#692Different dendritic cell subsets
#693Method for immunotherapy of tumors
#694Loading of cells with antigens by electroporation
#695In situ maturation of dendritic cells
#696Control of indoleamine 2,3 deoxygenase expression and activity
#697Human lineage committed cell composition with enhanced proliferative potential, biological effector function, or both: methods for obtaining same; and their uses
#698Mature dendritic cell compositions and methods for culturing same
#699Dendritic cell nodes
#700Method for activating human antigen presenting cells, activated human antigen - presenting cells, and use thereof
#701Method for making dendritic cell vaccines from embryonic stem cells
#702Preloaded dendritic cell vaccines for treating cancer
#703Administration of dendritic cells partially matured in vitro for the treatment of tumors
#704Pharmaceutical composition for inducing an immune response in a human or animal
#705Modified dendritic cells
#706Generation of dendritic cells from cd34+precursors
#707Transcutaneous and/or transdermal transport of materials
#708Dendritic cell line
#709Methods for treating tumors and cancerous tissues
#710Compositions and methods to select dendritic cells from a heterogeneous cell population
#711Modified adenoviral vectors for use in vaccines and gene therapy
#712CD70 inhibition for the treatment and prevention of inflammatory bowel disease
#713Immune regulation
#714Methods related to immunostimulatory nucleic acid-induced interferon
#715Methods for producing functional antigen presenting dendritic cells using biodegradable microparticles for delivery of antigenic materials
#716Methods for promoting antigen presentation and modulating immune responses using cholera toxin and its b subunit
#717Monocyte-derived dendritic cell subsets
#718Immunomodulatory polymeric antigens for treating inflammatory pathologies
#719Modulation of stem and progenitor cell differentiation, assays, and uses thereof
#720Use of discoidin domain receptor 1 (DDR1) and agents that affect the DDR1/collagen pathway
#721Method for culturing dendritic cells
#722Methods for inducing the differentiation of blood monocytes into functional dendritic cells
#723Methods and compositions for producing antigenic responses
#724Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells
#725Method of inducing maturation of dendritic cells and uses therefor
#726Compositions and methods for priming monocytic dendritic cells and t cells for th-1response
#727Nucleotide regulation of immune responses
#728Method of treating or preventing disease characterized by cryptococcus neoformans infection
#729Generation and use of new types of dendritic cells
#730Vesiles derived from t cells, production and uses
#731Chimeric antigens for breaking host tolerance to foreign antigens
#732In vitro production of dendritic cells from CD14+ monocytes
#733Mature type-1 polarized dendritic cells with enhanced IL-12 production and methods of serum-free production and use
#734Modified antigen-presenting cells
#735Dendritic cell preparation and preparation method thereof
#736COVID-19 peptide specific T-cells and methods of treating and preventing COVID-19
#737COVID-19 peptide specific T-cells and methods of treating and preventing COVID-19
#738COVID-19 peptide specific T-cells and methods of treating and preventing COVID-19
#739Medium system and method for ex vivo expansion of NK cells
#740Composition of matter and methods for alteration of dendritic cell metabolism to augment cancer vaccine efficacy